Platelet Poor Plasma vs Corticosteroids for Musculoskeletal Injuries

This trial examines two treatments for thigh muscle injuries in athletes, aiming to determine which helps players return to the game faster: corticosteroid injections or platelet-poor plasma (PPP) injections. It is ideal for young athletes with a recently confirmed thigh muscle injury. Participants should not have had recent injections or require surgery for their injury. As a Phase 4 trial, the treatments are already FDA-approved and proven effective, and this research seeks to understand how they can benefit more patients.

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

A previous study showed promising results for platelet-poor plasma (PPP) in treating muscle injuries. Reports suggest that PPP may aid recovery and has been used safely by athletes without serious side effects. Notably, these cases reported no serious adverse events or infections.

Corticosteroids, commonly used to reduce inflammation, are well-known and FDA-approved for various conditions. They are generally well-tolerated, though some people may experience side effects like increased appetite, mood changes, or trouble sleeping.

Unlike standard treatments for musculoskeletal injuries, which often involve corticosteroid injections to reduce inflammation and pain, platelet poor plasma (PPP) therapy is an innovative approach that aims to utilize the body's own healing mechanisms. Researchers are excited about PPP because it involves injecting plasma derived from the patient's own blood, minus the platelets, which is believed to promote tissue healing and regeneration without the potential side effects of steroids. This method could offer a more natural and potentially safer alternative, particularly for individuals who may not respond well to traditional corticosteroid treatments.

This trial will compare the effectiveness of corticosteroid injections and platelet-poor plasma (PPP) for musculoskeletal injuries. Studies have shown that corticosteroid injections effectively reduce swelling and pain in muscle injuries. Athletes have used this treatment successfully for many years to return to sports more quickly. In contrast, PPP is a newer treatment under investigation in this trial. Some reports suggest that PPP might aid in healing and muscle repair. However, less information is available about PPP compared to corticosteroids. Both treatments show promise, but corticosteroids have a longer history of use.¹⁶⁷⁸⁹